Advertise Follow Us
Formerly known as the animal-health division of Pfizer, Zoetis became a stand-alone company with a singular focus earlier this year. The name roughly translates from the derived Latin word zoetic, which means pertaining to life.
Pfizer, which in February of this year owned 83% of the new company’s publicly-traded stock, will concentrate on human health products and issues while Zoetis will provide veterinarians, livestock producers and pet owners with essential animal-health medicines, vaccines and services.
Building on a 60-year history as the animal-health business at Pfizer, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a wide range of services.
Generating annual revenues of $4.3 billion in 2012, the company has more than 9,300 employees worldwide and a local presence in 70 countries, including 29 manufacturing facilities in 11 countries.